MA28544B1 - Facteur de permissivité cellulaire pour virus, et leurs utilisations - Google Patents

Facteur de permissivité cellulaire pour virus, et leurs utilisations

Info

Publication number: MA28544B1
Authority: MA; Morocco
Prior art keywords: viruses; cell; factor; permissivity factor; cell permissivity
Prior art date: 2004-04-23

Application number

MA29400A

Other languages

English (en)

Inventor

Jay Gregory Calvert

Shelly Lynn Shields

David Ewell Slade

Siao-Kun Wan Welch

Original Assignee

Pharmacia & Upjohn Co Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-23

Filing date

2006-10-20

Publication date

2007-04-03

2006-10-20 Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc

2007-04-03 Publication of MA28544B1 publication Critical patent/MA28544B1/fr

Links

241000700605 Viruses Species 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0688—Cells from the lungs or the respiratory tract
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12051—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
Pharmacology & Pharmacy (AREA)
Toxicology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

MA29400A 2004-04-23 2006-10-20 Facteur de permissivité cellulaire pour virus, et leurs utilisations MA28544B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US56521404P	2004-04-23	2004-04-23
US63473604P	2004-12-09	2004-12-09

Publications (1)

Publication Number	Publication Date
MA28544B1 true MA28544B1 (fr)	2007-04-03

Family

ID=35320736

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29400A MA28544B1 (fr)	2004-04-23	2006-10-20	Facteur de permissivité cellulaire pour virus, et leurs utilisations

Country Status (21)

Country	Link
US (4)	US7754464B2 (fr)
EP (2)	EP2520310B1 (fr)
JP (2)	JP5273642B2 (fr)
CN (1)	CN102220289B (fr)
AR (3)	AR049033A1 (fr)
AU (2)	AU2005240002B2 (fr)
BR (1)	BRPI0508928B1 (fr)
CA (1)	CA2564769C (fr)
CL (1)	CL2008002323A1 (fr)
DK (1)	DK1742658T3 (fr)
EA (1)	EA013071B1 (fr)
ES (2)	ES2530694T3 (fr)
IL (1)	IL178160A0 (fr)
MA (1)	MA28544B1 (fr)
MX (1)	MXPA06012216A (fr)
NO (1)	NO341211B1 (fr)
NZ (1)	NZ550145A (fr)
PL (1)	PL1742658T3 (fr)
TW (2)	TWI438278B (fr)
UY (1)	UY28867A1 (fr)
WO (1)	WO2005107796A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2564769C (fr) *	2004-04-23	2013-12-17	Pharmacia & Upjohn Company Llc	Facteur de permissivite cellulaire pour virus, et son utilisation
US8202717B2 (en) *	2007-01-12	2012-06-19	The Board Of Trustees Of The University Of Illinois	Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus
AU2008290914A1 (en) *	2007-07-27	2009-02-26	Universiteit Gent	Permissive cells and uses thereof
UA108902C2 (uk) *	2010-11-10	2015-06-25		Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
CA2872789C (fr)	2012-05-17	2019-09-03	Zoetis Llc	Vaccination efficace contre le virus du syndrome reproducteur et respiratoire porcin (srrp) avant le sevrage
CN103525766B (zh) *	2013-03-24	2015-06-17	西北农林科技大学	一种猪肾细胞系及其应用
GB201313235D0 (en)	2013-07-24	2013-09-04	Univ Edinburgh	Antiviral Compositions Methods and Animals
CN104459160A (zh) *	2014-12-30	2015-03-25	洛阳普莱柯万泰生物技术有限公司	试剂盒及其制备方法和使用方法
GB201617559D0 (en)	2016-10-17	2016-11-30	University Court Of The University Of Edinburgh The	Swine comprising modified cd163 and associated methods
CN110072547B (zh)	2016-12-14	2024-04-30	硕腾服务有限责任公司	断奶前对抗欧洲猪繁殖与呼吸综合征(prrs)病毒株的有效疫苗接种
CN108103099B (zh) *	2017-12-18	2022-03-04	中山大学	一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) *	2018-08-13	2022-04-19	江苏省农业科学院	先天性免疫系统重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) *	2020-02-06	2020-11-27	广西大学	猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) *	2020-03-23	2021-05-20	큐벳 주식회사	항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) *	2020-04-22	2023-10-24	The United States Of America, As Represented By The Secretary Of Agriculture	Continuous stable cell line for identification of infectious African swine fever virus in clinical samples
WO2024123640A1 (fr)	2022-12-06	2024-06-13	Zoetis Services Llc	Procédés et compositions pour vacciner des porcelets contre le virus sdrp-1

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5622871A (en)	1987-04-27	1997-04-22	Unilever Patent Holdings B.V.	Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en)	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies
US4366241A (en)	1980-08-07	1982-12-28	Syva Company	Concentrating zone method in heterogeneous immunoassays
US4517288A (en)	1981-01-23	1985-05-14	American Hospital Supply Corp.	Solid phase system for ligand assay
CA1291031C (fr)	1985-12-23	1991-10-22	Nikolaas C.J. De Jaeger	Methode pour la detection de liants specifiques et des substances liables par ceux-ci
CA1303983C (fr)	1987-03-27	1992-06-23	Robert W. Rosenstein	Essai en phase solide
AU643427B2 (en)	1988-10-31	1993-11-18	Immunex Corporation	Interleukin-4 receptors
US5118937A (en)	1989-08-22	1992-06-02	Finnigan Mat Gmbh	Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
ES2151463T5 (es)	1989-12-22	2012-10-29	Merck Serono Sa	Constructos de ADN para la activación y la modificación de la expresión de genes endógenos
WO1991018982A1 (fr)	1990-06-05	1991-12-12	Immunex Corporation	Recepteurs de l'interleukine-1 de type ii
AU664847B2 (en)	1991-05-15	1995-12-07	Cell Genesys, Inc.	Genomic modifications with homologous DNA targeting
US5846805A (en)	1991-08-26	1998-12-08	Boehringer Ingelheim Animal Health, Inc.	Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en)	1992-06-11	1996-05-07	Trustees Of The University Of Pennsylvania	Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en)	1992-12-03	2000-08-21	Transkaryotic Therapies Inc	Protein production and protein delivery
EP0700521B1 (fr)	1993-05-28	2003-06-04	Baylor College Of Medicine	Procedes et spectrometre de masse pour la desorption et l'ionisation d'analytes
ES2165405T3 (es) *	1994-04-11	2002-03-16	Akzo Nobel Nv	Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
US5807522A (en)	1994-06-17	1998-09-15	The Board Of Trustees Of The Leland Stanford Junior University	Methods for fabricating microarrays of biological samples
WO1998035023A1 (fr) *	1997-02-07	1998-08-13	Origen, Inc.	Procede servant a cultiver le virus du syndrome respiratoire et reproductif porcin afin de l'utiliser en tant que vaccin et dans des essais diagnostiques
US6740490B2 (en)	2001-01-29	2004-05-25	Kansas State University Research Foundation	Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
WO2003010200A2 (fr)	2001-07-24	2003-02-06	Akzo Nobel, N.V.	Acide nucleique codant pour un polypeptide intervenant dans l'entree cellulaire du virus sdrp
AU2003243058A1 (en) *	2002-05-27	2003-12-12	Bioceros B.V.	Methods for using the cd163 pathway for modulating an immune response
CA2564769C (fr) *	2004-04-23	2013-12-17	Pharmacia & Upjohn Company Llc	Facteur de permissivite cellulaire pour virus, et son utilisation

2005
- 2005-04-05 CA CA2564769A patent/CA2564769C/fr not_active Expired - Lifetime
- 2005-04-05 EP EP12178283.3A patent/EP2520310B1/fr not_active Expired - Lifetime
- 2005-04-05 EA EA200601677A patent/EA013071B1/ru not_active IP Right Cessation
- 2005-04-05 PL PL05736317T patent/PL1742658T3/pl unknown
- 2005-04-05 MX MXPA06012216A patent/MXPA06012216A/es active IP Right Grant
- 2005-04-05 NZ NZ550145A patent/NZ550145A/en not_active IP Right Cessation
- 2005-04-05 ES ES05736317T patent/ES2530694T3/es not_active Expired - Lifetime
- 2005-04-05 JP JP2007509491A patent/JP5273642B2/ja not_active Expired - Lifetime
- 2005-04-05 BR BRPI0508928A patent/BRPI0508928B1/pt active IP Right Grant
- 2005-04-05 WO PCT/US2005/011502 patent/WO2005107796A2/fr not_active Ceased
- 2005-04-05 DK DK05736317T patent/DK1742658T3/en active
- 2005-04-05 AU AU2005240002A patent/AU2005240002B2/en not_active Expired
- 2005-04-05 EP EP05736317.8A patent/EP1742658B1/fr not_active Expired - Lifetime
- 2005-04-05 ES ES12178283T patent/ES2570665T3/es not_active Expired - Lifetime
- 2005-04-05 CN CN201110127305.5A patent/CN102220289B/zh not_active Expired - Lifetime
- 2005-04-20 TW TW100121989A patent/TWI438278B/zh not_active IP Right Cessation
- 2005-04-20 TW TW94112572A patent/TWI354025B/zh not_active IP Right Cessation
- 2005-04-22 AR ARP050101615 patent/AR049033A1/es active IP Right Grant
- 2005-04-22 UY UY28867A patent/UY28867A1/es not_active Application Discontinuation
- 2005-04-25 US US11/113,751 patent/US7754464B2/en active Active
2006
- 2006-09-18 IL IL178160A patent/IL178160A0/en unknown
- 2006-10-20 MA MA29400A patent/MA28544B1/fr unknown
- 2006-11-06 NO NO20065115A patent/NO341211B1/no unknown
2008
- 2008-08-07 CL CL2008002323A patent/CL2008002323A1/es unknown
2009
- 2009-06-16 AU AU2009202410A patent/AU2009202410A1/en not_active Abandoned
2010
- 2010-05-06 US US12/775,283 patent/US8058050B2/en not_active Expired - Lifetime
2011
- 2011-09-29 US US13/248,537 patent/US8486685B2/en not_active Expired - Lifetime
- 2011-12-21 AR ARP110104870 patent/AR084529A2/es unknown
- 2011-12-21 AR ARP110104871 patent/AR084530A2/es unknown
2012
- 2012-11-22 JP JP2012256338A patent/JP5600340B2/ja not_active Expired - Lifetime
2013
- 2013-07-12 US US13/940,317 patent/US9102912B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL178160A0 (en)	2006-12-31
NO341211B1 (no)	2017-09-11
ES2530694T3 (es)	2015-03-04
WO2005107796A2 (fr)	2005-11-17
AR084530A2 (es)	2013-05-22
AR049033A1 (es)	2006-06-21
WO2005107796A3 (fr)	2007-04-12
CN102220289A (zh)	2011-10-19
US20120015425A1 (en)	2012-01-19
JP5600340B2 (ja)	2014-10-01
US20140141492A1 (en)	2014-05-22
EP1742658B1 (fr)	2014-12-24
TWI438278B (zh)	2014-05-21
CL2008002323A1 (es)	2008-12-19
EP2520310A1 (fr)	2012-11-07
JP2013078324A (ja)	2013-05-02
CA2564769A1 (fr)	2005-11-17
EP2520310B1 (fr)	2016-03-30
BRPI0508928B1 (pt)	2015-10-06
CA2564769C (fr)	2013-12-17
US8486685B2 (en)	2013-07-16
AR084529A2 (es)	2013-05-22
AU2005240002B2 (en)	2009-06-18
US20050271685A1 (en)	2005-12-08
JP5273642B2 (ja)	2013-08-28
US20100273238A1 (en)	2010-10-28
NO20065115L (no)	2006-11-06
ES2570665T3 (es)	2016-05-19
MXPA06012216A (es)	2007-01-17
JP2007533321A (ja)	2007-11-22
AU2005240002A1 (en)	2005-11-17
NZ550145A (en)	2009-07-31
EP1742658A2 (fr)	2007-01-17
HK1109065A1 (en)	2008-05-30
AU2009202410A1 (en)	2009-07-09
DK1742658T3 (en)	2015-01-19
TWI354025B (en)	2011-12-11
US9102912B2 (en)	2015-08-11
CN102220289B (zh)	2014-05-21
TW200604343A (en)	2006-02-01
EA200601677A1 (ru)	2007-10-26
EA013071B1 (ru)	2010-02-26
EP1742658A4 (fr)	2007-11-28
US7754464B2 (en)	2010-07-13
US8058050B2 (en)	2011-11-15
UY28867A1 (es)	2005-11-30
BRPI0508928A (pt)	2007-08-14
TW201134944A (en)	2011-10-16
PL1742658T3 (pl)	2015-05-29

Publication	Publication Date	Title
MA28544B1 (fr)	2007-04-03	Facteur de permissivité cellulaire pour virus, et leurs utilisations
FR20C1019I2 (fr)	2021-10-15	Promedicaments de composes de 2,4-pyrimidinediamine et leurs utilisations
EP1773878A4 (fr)	2012-06-20	Conjugués insuline-oligomère, préparations et utilisations de ceux-ci
EP1868650A4 (fr)	2010-12-01	Di-anticorps covalents et leurs utilisations
EP1812062A4 (fr)	2012-12-19	Anticorps anti-addl et leurs utilisations
EP1771183A4 (fr)	2008-10-08	Copolymeres antimicrobiens et leurs utilisations
DE602006012336D1 (de)	2010-04-01	Radikalische atomtransfer-polymerisation in mikroemulsion und echte emulsionspolymerisation
DE60130633D1 (de)	2007-11-08	Gesicherte Internet-Zwischenablage
EP1737884A4 (fr)	2008-10-29	Alpha-mimetiques helicoidales, leurs utilisations et leurs procedes de production
EP2124551A4 (fr)	2010-07-28	1,3-dioxanes substitués et leurs utilisations
IL179545A (en)	2010-12-30	Viral and viral associated mirnas and uses thereof
HUE039237T2 (hu)	2018-12-28	B7-H1 és PD-1 vesesejt karcinoma kezelésében
NO20082454L (no)	2008-07-17	Anti-alfa2 integrin antistoffer og deres anvendelser
EP1727560A4 (fr)	2009-09-09	Facteur proliferatif gastro-intestinal et utilisations de celui-ci
EP1943341A4 (fr)	2010-07-07	Epitopes de barriere hematoencephalique et leurs utilisations
EP1883341A4 (fr)	2014-09-10	Systemes fluidiques situes des points de service et leurs utilisations
NO20070772L (no)	2007-02-09	Direkte valutakonvertering.
TW200609706A (en)	2006-03-16	Network interface controller circuitry
EP1723238A4 (fr)	2007-07-04	Virus oncolytiques modifies
EP1723247A4 (fr)	2007-10-03	Perforine de recombinaison, expression et utilisations
DE602004012059D1 (de)	2008-04-10	Techniken zum dynamischen Aufbauen und Handhaben von Authentisierung und Vertrauensverhältnissen
EP1753468A4 (fr)	2010-05-26	Carboranylporphyrines et utilisations associees
EP1846329A4 (fr)	2009-09-16	Extraction d'alumine
FR2873123B1 (fr)	2006-09-15	Nouveaux glycopolymeres, leurs utilisations, et monomeres utiles pour leur preparation
EP1633310A4 (fr)	2006-10-18	Analogues de thiotungstate et leurs utilisations